Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Metlife Inc : MetLife Posts Wider 1Q Loss Than Projected On Larger Investment Losses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/27/2012 | 04:08am CEST

("MetLife Posts Wider 1Q Loss Than Projected On Smaller Tax Benefit," published at 4:59 p.m. EDT, and a correction at 5:38 p.m. misstated the reason for MetLife's wider loss. The correct version follows:)

MetLife Inc. (MET) reported a wider first-quarter loss than it projected last week as the life insurer posted larger net investment losses.

Last Friday, the biggest U.S. insurer reported preliminary results after inadvertently posting some of its financial data on its website ahead of the scheduled release.

The company posted a loss of $144 million, or 16 cents a share, widening from the $64 million it estimated last week and compared with the year-earlier profit of $877 million. It posted net investment losses of $110 million, versus the $30 million projected last week.

Operating earnings, which exclude investment gains and losses, came in at $1.37 a share, as reported last Friday. Operating revenue, which likewise strips out some investment effects, also was unchanged at $16.69 billion, up 6.9%.

The bottom-line result was driven by net derivative losses of $1.98 billion, while the year-earlier period's loss was a mere $315 million. Like its fellow insurers, MetLife uses derivatives to hedge a number of risks, including changes in interest rates and fluctuations in foreign currencies.

MetLife said earlier Thursday it is selling its reverse-mortgage business, its latest move to avoid increased regulatory scrutiny and stay focused on its core operations.

In March, it failed "stress tests" by the Federal Reserve that were aimed at gauging the capital adequacy of 19 of the biggest U.S. financial firms under a severe economic worsening.

MetLife shares closed Thursday at $36.47 and were inactive after hours. The stock is up 17% so far this year.

-By Lauren Pollock, Dow Jones Newswires; 212-416-2356; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
10/19 METLIFE : Shareholders Approve Proposal at Special Meeting
10/14 INTERNATIONAL BUSINESS MACHINES : IBM brings insurance platform to market
10/14 METLIFE : Selected as a Provider for the U.S. Department of Veterans Affairs Den..
10/11 IBM : Introduces Industry Platform Designed Specifically for Insurers
10/11 METLIFE : Announces 6 Finalists for "collab 2.0"
10/10 METLIFE : Announces 6 Finalists for “collab 2.0”
10/05 METLIFE : Tenth year in a row that MetLife is recognized by Dave Thomas Foundati..
10/04 METLIFE : Auto & Home® Introduces 100% Digital Products on Guidewire Platform
10/04 A.M. BEST : Affirms Credit Ratings of MetLife Inc. and Its Subsidiaries
10/04 METLIFE : to Hold Conference Call for Third Quarter 2017 Results
More news
News from SeekingAlpha
10/18 BRIGHTHOUSE FINANCIAL : Fundamental Headwinds Priced In; 25% Upside For Insuranc..
10/17 Prudential up more than 1% after Citi upgrade
10/16 Dividend Growth Portfolio Update
10/14 Stocks to watch next week
10/13 Valuing Brighthouse Financial. Is It Deeply Discounted?
Financials ($)
Sales 2017 63 809 M
EBIT 2017 5 878 M
Net income 2017 3 688 M
Debt 2017 -
Yield 2017 3,03%
P/E ratio 2017 16,61
P/E ratio 2018 10,66
Capi. / Sales 2017 0,89x
Capi. / Sales 2018 0,89x
Capitalization 56 544 M
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 55,5 $
Spread / Average Target 4,1%
EPS Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Martin J. Lippert Executive VP-Global Technology & Operations
John C. R. Hele Chief Financial Officer & Executive Vice President
Jacki Goldstein Chief Medical Officer
Cheryl W. Grisé Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE-1.11%56 544
AXA5.46%72 814
PRUDENTIAL12.81%63 638
PRUDENTIAL FINANCIAL INC4.64%47 676
MANULIFE FINANCIAL CORP.7.34%40 784
AFLAC INCORPORATED21.34%33 140